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ense (http://creativecommons.org/In recent years, intensive research has focused on the
interplay between heart and kidney function. An important
example is the recently described cardiorenal syndrome,
which highlights the effects of acute or chronic dysfunction
of one structure on the other.1 However, apart from heart
failure, the dynamic interaction between heart and kidneys
holds crucial clinical and prognostic significance in a wide
spectrum of cardiac disorders (e.g., coronary heart disease,
cardiomyopathies) where renal dysfunction may affect
cardiac function.2-4 The important question of whether
prevention or effective treatment of renal impairment can
improve outcomes in patients with concomitant cardiac
disorders is still awaiting a definitive response.4
In the context of coronary artery disease, the coexis-
tence of chronic kidney disease is a familiar scenario. The
presence of common risk factors such as hypertension,
diabetes mellitus and atherosclerosis may account for this
combination.4
Patients hospitalized for acute coronary syndromes with
underlying chronic kidney disease have a higher risk of
adverse outcomes.5 The overall contribution of impaired
renal function to these outcomes is emphasized by they of Hellenic Cardiological
.04.002
cal Society. Publishing services by
licenses/by-nc-nd/4.0/).widely used GRACE risk score (a validated calculation of
six-month mortality in acute coronary syndrome), where
baseline creatinine value is the fifth-highest predictor of
death.6,7
Previous studies have addressed the impact of renal
dysfunction in patients with acute ST-elevation myocar-
dial infarction (STEMI) undergoing primary percutaneous
coronary intervention (PCI). In this setting, among a
cohort of more than 9,000 patients, advanced chronic
kidney disease (at least stage 3, but not on dialysis) was
independently associated with significantly worse in-
hospital outcomes (unadjusted mortality 23.4%, vs 4.2%
in the group without advanced kidney disease) even after
adjustment for comorbidities.8 Similarly, data from the
HORIZONS-AMI trial revealed that STEMI patients with
renal impairment undergoing primary PCI had higher long-
term rates of death (18.7% vs. 4.4%, p < 0.0001) and major
bleeding (19.3% vs. 6.7%, p < 0.0001) than did patients
with normal kidney function. More specifically, in multi-
variable analysis, baseline creatinine emerged as an in-
dependent predictor of death at the three-year follow-up
(HR Z 1.51).9
To identify gender differences in the prevalence and
prognostic impact of kidney function impairment in the
setting of STEMI, 1,638 patients undergoing primary PCI
were assessed in one study.10 Women were found to suffer
from kidney dysfunction more frequently than men in this
study (42.3% vs. 25.3%, p < 0.001). This manifested in a
two-fold relative increase of female in-hospital mortality
(Odds Ratio 2.12, p < 0.001). In multivariable analysis,
impaired renal function emerged as an independent pre-
dictor of in-hospital mortality in both genders (OR Z 2.39,
p Z 0.007).
In a similar single-center study of 274 STEMI patients
undergoing primary PCI, a higher prevalence of renal
insufficiency (defined as estimated glomerular filtration
rate (eGFR) <60 ml/min) among females was confirmedElsevier B.V. This is an open access article under the CC BY-NC-ND
Figure 1 Schematic representation of the highlights of the Savic L et al. study. STEMI Z ST elevation myocardial infarction,
pPCI Z primary percutaneous coronary intervention, EF Z ejection fraction, eGFR Z estimated glomerular filtration rate.
Editorial 117(67% vs. 26%, OR Z 5.06). Interestingly, an association
between eGFR increase (by 10mL/min) and reduction of
one-year mortality was noted among the women studied,
(OR Z 0.39) but not the men.11
In this issue of the Hellenic Journal of Cardiology, Savic
L. et al. assessed the prognostic contribution of chronic
kidney disease (defined as eGFR<60mL/min) to five-year
all-cause mortality in men and women with STEMI under-
going primary PCI.12 The novelty of this investigation con-
sists of both the inclusion only of patients with impaired
left ventricular systolic function (ejection fraction <40%)
and, most importantly, the extended length of follow-up.
The study population consisted of 348 patients (29.8%
women). In accordance with previous observations, chronic
kidney disease was more common in women than in men
(54.8% vs. 22.5%, p < 0.001), and female gender emerged as
an independent predictor of renal dysfunction. No signifi-
cant difference in five-year all-cause mortality was found
between men and women (27.8% vs 23.3%, p Z 0.370),
whereas in multivariable analysis, chronic kidney disease
was an independent predictor of five-year mortality only in
men. This finding is inconsistent with the results of other
available studies, however, and needs confirmation from
study of larger populations. The highlights of the latter
study are summarized in Fig. 1.
In conclusion, renal dysfunction is more prevalent in fe-
male versus male STEMI patients undergoing primary PCI.Renal function impairment confers adverse outcomes in both
genders. The poor outcome in patients with renal dysfunction
is multifactorial, with contributions including the high prev-
alence of concomitant risk factors, the greater risk of
contrast-induced nephropathy and the higher risk of
bleeding.13 Nonetheless, it is not completely clear why the
incidence of renal dysfunction is higher inwomen than inmen.
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